articleCirculationApr 25, 2016BRONZE OA

Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device

Texas Cardiac Arrhythmia

PubMed
Indexed incrossrefpubmed

Abstract

BACKGROUND: Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. METHODS AND RESULTS: This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction

Citation impact

853
total citations
FWCI
59.12
Percentile
100%
References
39
Citations per year

Authors

26

Topics & keywords

Keywords
  • Medicine
  • Amiodarone
  • Hazard ratio
  • Atrial fibrillation
  • Confidence interval
  • Ejection fraction
  • Cardiology
  • Heart failure
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.